{"id":"https://genegraph.clinicalgenome.org/r/442c2327-a3c1-4e0f-bf7a-f0136a3ad108v1.0","type":"EvidenceStrengthAssertion","dc:description":"POLR1D has been repeatedly described in association with autosomal dominant Treacher Collins Syndrome 2 (TCS2). TCS2 is a disorder of craniofacial development characterized by downward slanting palpebral fissures, coloboma, hypoplasia of the facial bones, cleft palate, malformation of the external ears, and bilateral conductive hearing loss. At least 3 missense and 5 nonsense variants have been reported in at least 10 probands from 5 publications (PMIDs: 21131976, 25790162, 31107123, 34397304, 34136434). In addition to these variants, there has been one missense variant (p.Leu55Val) determined to have an autosomal recessive mode of inheritance in three unrelated probands (PMIDs: 24603435, 25790162). However, this information was not scored for autosomal dominant TCS2. This gene disease association is also supported by experimental evidence including protein interactions and an animal model (PMIDs: 8955128, 27448281).  In summary, POLR1D is definitively associated with autosomal dominant Treacher Collins Syndrome 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations Gene Curation Expert Panel on 12/15/2022. (SOP Version 9)","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/442c2327-a3c1-4e0f-bf7a-f0136a3ad108","GCISnapshot":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2025-05-27T23:49:29.298Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2022-12-15T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a47fee9d-4e2c-44cd-be0a-5a7007396af3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d0d9356-6082-4d0c-b3b5-8cb1583db031","type":"Finding","dc:description":"Polr1c-/- and polr1d-/- mutant embryos were phenotypically distinguishable from their control siblings as early as 24 hpf by their smaller eyes, disrupted midbrain-hindbrain boundary and necrotic cranial tissue. At 3 dpf, polr1c-/- and polr1d-/- mutants were distinguishable from control siblings by their smaller heads, microphthalmia, and hyploplastic jaws. Alcian blue staining revealed cartilage is hypoplastic in polr1c-/- and polr1d-/- mutants 5 dpf compared to controls. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27448281","rdfs:label":"Noack Watt_Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2b72698-2963-4391-9cb7-816a2c901134","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46e1fb81-d889-433e-b0b6-90b3a21f44c5","type":"Finding","dc:description":"Using yeast 2-hybrid analysis, they showed that mouse RPA16 (POLR1D homolog) interacted with mouse RPA40 (POLR1C homolog), and mutation analysis revealed that the alpha motif of RPA40 was required for the interaction. Neither RPA40 nor RPA16 could self-associate in the yeast 2-hybrid system.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8955128","rdfs:label":"Yao_yeast 2-Hybrid","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/be9f1e40-dd42-40af-a429-6f4cfd74a7c2_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e766c5d-d561-4673-a4d7-46ee4dd17225","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e766c5d-d561-4673-a4d7-46ee4dd17225_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25790162","allele":{"id":"https://genegraph.clinicalgenome.org/r/141fed7b-e7e3-43aa-9b42-2535c436e14f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.259C>T (p.Arg87Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA387635620"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d93951a4-7215-4c81-8e27-7ed1d92201be","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d93951a4-7215-4c81-8e27-7ed1d92201be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131976","allele":{"id":"https://genegraph.clinicalgenome.org/r/6b4c5fc0-d536-4160-b40e-a522f86bc5e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.152T>G (p.Leu51Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA387635144"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a53b2e98-5981-493c-bd2d-e401c31247f8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a53b2e98-5981-493c-bd2d-e401c31247f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25790162","allele":{"id":"https://genegraph.clinicalgenome.org/r/ff1f340a-12a1-49f2-ad84-2a4645549584","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.188del (p.Pro63ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332357"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bf19273b-29a9-4eaa-bbca-c3e29dae42bb","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf19273b-29a9-4eaa-bbca-c3e29dae42bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31107123","allele":{"id":"https://genegraph.clinicalgenome.org/r/c96baf0a-63c7-4f8d-b116-dd0a3d71acfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.91C>T (p.Gln31Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA387634900"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d7958513-5639-4c27-b0e0-fbd1e7ae3f87","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7958513-5639-4c27-b0e0-fbd1e7ae3f87_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131976","allele":{"id":"https://genegraph.clinicalgenome.org/r/ecec5774-ddb3-4c87-a590-8076fe86cf6d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.326_327del (p.His109fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/31052"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cea6f4a2-42b1-49a8-86a4-5143a27b669e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cea6f4a2-42b1-49a8-86a4-5143a27b669e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25790162","allele":{"id":"https://genegraph.clinicalgenome.org/r/668bbe54-8617-4e08-9155-6588ada9486e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.171C>G (p.Tyr57Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA387635198"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3d3a89dd-9acb-43bd-b9df-ebac33805ff3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d3a89dd-9acb-43bd-b9df-ebac33805ff3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131976","allele":{"id":"https://genegraph.clinicalgenome.org/r/141fed7b-e7e3-43aa-9b42-2535c436e14f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/86e51c5a-9011-4285-878e-4232840eb5a7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86e51c5a-9011-4285-878e-4232840eb5a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34397304","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac55aa56-2150-42c7-bfc6-feeafbb27a81","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.139G>A (p.Glu47Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6927259"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/504e59f1-008a-41d6-a882-a9f7d1bf7ab9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/504e59f1-008a-41d6-a882-a9f7d1bf7ab9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34136434","allele":{"id":"https://genegraph.clinicalgenome.org/r/141fed7b-e7e3-43aa-9b42-2535c436e14f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/506f462d-c5a2-48c5-8ee2-4ea186f52bf9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/506f462d-c5a2-48c5-8ee2-4ea186f52bf9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25790162","allele":{"id":"https://genegraph.clinicalgenome.org/r/b87447a9-6b97-4234-b4de-b0093dc1de3e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015972.4(POLR1D):c.155G>A (p.Gly52Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA387635150"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.2}],"evidenceStrength":"Definitive","sequence":10487,"specifiedBy":"GeneValidityCriteria9","strengthScore":13.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/197odh8HhYA","type":"GeneValidityProposition","disease":"obo:MONDO_0013385","gene":"hgnc:20422","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_be9f1e40-dd42-40af-a429-6f4cfd74a7c2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}